BioCentury
ARTICLE | Finance

New fund to expand Anlong’s tool kit for early stage deals

With a new U.S. dollar fund Anlong aims to fund Chinese companies looking to list in Hong Kong or overseas

June 29, 2019 2:23 AM UTC

Anlong Fund is seeking to raise $100 million for its first dollar-denominated fund that would be nearly double the size of the the Chinese firm’s two renminbi funds. The goal is to sidestep regulatory red tape and facilitate investment in early stage Chinese companies looking to list in Hong Kong or overseas, and U.S. companies planning to enter the China market.

Anlong focuses on seed through series B investments with a preference for leading syndicates and forming companies, according to founder and Managing Partner Adam Zhao, who is a veteran of CBG Group (formerly C-Bridge Capital) and Chinese Academy of Sciences (CAS) subsidiary CASH Capital. He is also the founder of Longmed Inc., a medical device and life science instrument distribution company in China. ...